• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基线时的相对脂肪量及其早期变化可能是非酒精性脂肪性肝病发病的一个预测指标。

Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.

作者信息

Kim Hwi Young, Baik Su Jung, Lee Hye Ah, Lee Byoung Kwon, Lee Hye Sun, Kim Tae Hun, Yoo Kwon

机构信息

Department of Internal Medicine, College of Medicine, Ewha Womans University, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea.

Healthcare Research Team, Health Promotion Center, Gangnam Severance Hospital, Seoul, Republic of Korea.

出版信息

Sci Rep. 2020 Oct 15;10(1):17491. doi: 10.1038/s41598-020-74659-9.

DOI:10.1038/s41598-020-74659-9
PMID:33060775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7567080/
Abstract

The relationship between changes in body components and the risk of nonalcoholic fatty liver disease (NAFLD) is not fully understood. We investigated the effects of body components and subsequent changes on incident NAFLD at follow-up ultrasound scanning in a longitudinal cohort. We included 9967 participants without NAFLD at baseline who underwent serial health examinations. Sex-specific, weight-adjusted skeletal muscle index (SMI) was used. Mean follow-up duration was 48.5 ± 33.5 months. NAFLD developed in 2395 participants (24.0%). Body composition was measured using bioelectrical impedance analysis. The following baseline body components were significantly associated with incident NAFLD: the lowest and middle SMI tertiles in the normal-weight group (adjusted hazard ratio [aHR] = 2.20 and 1.54, respectively), and fat percentage in the normal-weight (aHR = 1.12), overweight (aHR = 1.05), and obese groups (aHR = 1.03) (all P < 0.05). Among 5,033 participants who underwent ≥ 3 health examinations, SMI increase between the first and second examinations was an independent protective factor against incident NAFLD in non-obese groups (P < 0.05). Increased fat percentage was an independent risk factor for incident NAFLD in all weight categories (P < 0.05). High fat mass at baseline may be a better predictor of incident NAFLD than muscle mass. Reciprocal changes in fat and muscle mass during the first year of follow-up predicted incident NAFLD in non-obese groups.

摘要

身体成分变化与非酒精性脂肪性肝病(NAFLD)风险之间的关系尚未完全明确。我们在一个纵向队列中,通过随访超声扫描研究了身体成分及其后续变化对新发NAFLD的影响。我们纳入了9967名基线时无NAFLD且接受了系列健康检查的参与者。使用了按性别和体重调整的骨骼肌指数(SMI)。平均随访时间为48.5±33.5个月。2395名参与者(24.0%)发生了NAFLD。使用生物电阻抗分析测量身体成分。以下基线身体成分与新发NAFLD显著相关:正常体重组中最低和中间SMI三分位数(调整后风险比[aHR]分别为2.20和1.54),以及正常体重组(aHR = 1.12)、超重组(aHR = 1.05)和肥胖组(aHR = 1.03)的脂肪百分比(均P < 0.05)。在接受≥3次健康检查的5033名参与者中,非肥胖组第一次和第二次检查之间SMI的增加是预防新发NAFLD的独立保护因素(P < 0.05)。脂肪百分比增加是所有体重类别中新发NAFLD的独立危险因素(P < 0.05)。基线时高脂肪量可能比肌肉量更能预测新发NAFLD。随访第一年脂肪和肌肉量的相互变化可预测非肥胖组的新发NAFLD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3855/7567080/3a91b0ce5764/41598_2020_74659_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3855/7567080/20c618e7e236/41598_2020_74659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3855/7567080/8e50425359b5/41598_2020_74659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3855/7567080/3a91b0ce5764/41598_2020_74659_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3855/7567080/20c618e7e236/41598_2020_74659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3855/7567080/8e50425359b5/41598_2020_74659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3855/7567080/3a91b0ce5764/41598_2020_74659_Fig3_HTML.jpg

相似文献

1
Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.基线时的相对脂肪量及其早期变化可能是非酒精性脂肪性肝病发病的一个预测指标。
Sci Rep. 2020 Oct 15;10(1):17491. doi: 10.1038/s41598-020-74659-9.
2
Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.骨骼肌量与非酒精性脂肪性肝病的关系:一项 7 年纵向研究。
Hepatology. 2018 Nov;68(5):1755-1768. doi: 10.1002/hep.30049. Epub 2018 Oct 14.
3
Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.年龄相关的骨骼肌量减少是发生非酒精性脂肪性肝病的独立危险因素:一项 10 年回顾性队列研究。
Gut Liver. 2019 Jan 15;13(1):67-76. doi: 10.5009/gnl18070.
4
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.非酒精性脂肪性肝病在鹿特丹研究中的表现:肌肉质量、肌少症、脂肪质量和脂肪分布。
J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10.
5
Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease.骨骼肌与体脂肪比值的增加可预测非酒精性脂肪肝患者转氨酶的下降。
J Gastroenterol. 2019 Feb;54(2):160-170. doi: 10.1007/s00535-018-1485-8. Epub 2018 Jun 14.
6
Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.瘦型非酒精性脂肪性肝病与中国西北地区健康人群 2 型糖尿病发病风险的关联:一项 2 年随访期的回顾性队列研究。
Front Endocrinol (Lausanne). 2023 Jun 26;14:1173757. doi: 10.3389/fendo.2023.1173757. eCollection 2023.
7
Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.骨骼肌量和腹型肥胖是肝脂肪变性的独立预测因子,两者相互作用可预测十年心血管疾病的发生率:来自 ATTICA 队列研究的数据。
Clin Nutr. 2022 Jun;41(6):1281-1289. doi: 10.1016/j.clnu.2022.03.022. Epub 2022 Mar 31.
8
Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.非肥胖非酒精性脂肪性肝病患者的心血管疾病风险。
Hepatol Commun. 2022 Feb;6(2):309-319. doi: 10.1002/hep4.1818. Epub 2021 Sep 2.
9
Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者低骨骼肌量与晚期肝纤维化的相关性。
J Gastroenterol Hepatol. 2019 Sep;34(9):1633-1640. doi: 10.1111/jgh.14607. Epub 2019 Feb 14.
10
Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.超重和肥胖非酒精性脂肪性肝病患者经体重调整的口服脂肪耐量试验后成纤维细胞生长因子19及胆汁酸合成的反应:一项非随机对照试验
BMC Gastroenterol. 2018 Jun 4;18(1):76. doi: 10.1186/s12876-018-0805-z.

引用本文的文献

1
Nonlinear relationship between body fat percentage and NAFLD mediated by METS-IR: threshold effects and subgroup differences.由代谢综合征胰岛素抵抗(METS-IR)介导的体脂百分比与非酒精性脂肪性肝病(NAFLD)之间的非线性关系:阈值效应和亚组差异。
Sci Rep. 2025 Jul 10;15(1):24917. doi: 10.1038/s41598-025-10765-w.
2
Bioelectrical impedance analysis parameters are superior to liver enzymes in predicting metabolic dysfunction-associated steatotic liver disease in young adults.在预测年轻成年人代谢功能障碍相关脂肪性肝病方面,生物电阻抗分析参数优于肝脏酶类。
Intern Emerg Med. 2025 Apr;20(3):785-795. doi: 10.1007/s11739-025-03880-z. Epub 2025 Apr 9.
3

本文引用的文献

1
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
2
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
3
2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea.
Association between Bioelectrical Impedance Parameters, Magnetic Resonance Imaging Muscle Parameters, and Fatty Liver Severity in Children and Adolescents.
儿童和青少年生物电阻抗参数、磁共振成像肌肉参数与脂肪肝严重程度之间的关联
Gut Liver. 2025 Jan 15;19(1):108-115. doi: 10.5009/gnl240342. Epub 2025 Jan 3.
4
Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes.非酒精性脂肪性肝病和2型糖尿病患者的区域脂肪分布、肝纤维化及脂肪变性严重程度
Obes Sci Pract. 2024 Jul 1;10(4):e777. doi: 10.1002/osp4.777. eCollection 2024 Aug.
5
Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.性别对代谢相关脂肪性肝病患者骨骼肌量的影响:基于倾向评分匹配研究。
J Nutr Health Aging. 2024 Jun;28(6):100270. doi: 10.1016/j.jnha.2024.100270. Epub 2024 Jun 3.
6
Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study.含糖饮料摄入量对黎巴嫩非酒精性脂肪性肝病患者肌肉减少性肥胖、内脏肥胖和肌肉减少症的影响:一项病例对照研究
Healthcare (Basel). 2024 Mar 5;12(5):591. doi: 10.3390/healthcare12050591.
7
Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador.厄瓜多尔瓜亚基尔市老年人腰围作为非酒精性脂肪性肝病的危险因素
Geriatrics (Basel). 2023 Apr 14;8(2):42. doi: 10.3390/geriatrics8020042.
8
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.瘦/非肥胖和肥胖个体中的非酒精性脂肪性肝病:关于患病率、发病机制、临床结局及治疗的综合综述
J Clin Transl Hepatol. 2023 Apr 28;11(2):502-515. doi: 10.14218/JCTH.2022.00204. Epub 2022 Dec 23.
9
The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.中国 2 型糖尿病患者肌少症和内脏型肥胖与非酒精性脂肪肝瘦体组织含量的关系。
J Diabetes Res. 2022 Nov 4;2022:2229139. doi: 10.1155/2022/2229139. eCollection 2022.
10
Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers.基于机器学习识别潜在的新型非酒精性脂肪性肝病生物标志物
Biomedicines. 2021 Nov 7;9(11):1636. doi: 10.3390/biomedicines9111636.
2018年韩国肥胖研究学会韩国肥胖管理指南
J Obes Metab Syndr. 2019 Mar;28(1):40-45. doi: 10.7570/jomes.2019.28.1.40. Epub 2019 Mar 30.
4
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.非酒精性脂肪性肝病在鹿特丹研究中的表现:肌肉质量、肌少症、脂肪质量和脂肪分布。
J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10.
5
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.亚洲地区非酒精性脂肪性肝病的流行率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.
6
Sarcopenia: revised European consensus on definition and diagnosis.肌少症:定义和诊断的欧洲共识修订版。
Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
7
Korea hypertension fact sheet 2018.《2018年韩国高血压情况说明书》
Clin Hypertens. 2018 Oct 1;24:13. doi: 10.1186/s40885-018-0098-0. eCollection 2018.
8
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.生活方式干预对非肥胖非酒精性脂肪性肝病患者的有益影响。
J Hepatol. 2018 Dec;69(6):1349-1356. doi: 10.1016/j.jhep.2018.08.011. Epub 2018 Aug 22.
9
Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status.《2016年韩国糖尿病情况说明书:现状评估》
Diabetes Metab J. 2018 Oct;42(5):415-424. doi: 10.4093/dmj.2018.0017. Epub 2018 Aug 9.
10
Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.年龄相关的骨骼肌量减少是发生非酒精性脂肪性肝病的独立危险因素:一项 10 年回顾性队列研究。
Gut Liver. 2019 Jan 15;13(1):67-76. doi: 10.5009/gnl18070.